Skip to main content

Table 1 Patient characteristics, treatment modalities, clinical parameters and patient outcome

From: Hemoadsorption by CytoSorb in septic patients: a case series

Case number Sex Age Source APACHE II Abx CytoSorb treatments (n) Delay (h) Cat-free days Details on renal outcome/recovery on ICU CRRT (days) Ventilation (days) Hospital stay (days) ICU stay (days) Predicted mortality 28-Day mortality ICU mortality Hospital mortality
1 M 76 Abd 45 Mero-Line-Cas 5 24 0 Non-recovery 15 17 17 17 97.5 Yes Yes Yes
2 M 58 Abd 48 Pip/T 3 24 7 Non-recovery 16 51 51 50 98.4 No Yes Yes
3 F 35 Abd 27 Pip/T-Clinda 2 24 28 Recovery 3 36 43 41 73.7 No No No
4 M 41 Abd 39 Mero-Fosfo 3 24 25 Recovery 13 27 36 36 94.2 No No No
5 F 58 Abd 27 Cefta-Levo 2 24 1 Non-recovery 2 3 4 4 73.7 Yes Yes Yes
6 M 75 Abd 37 Mero-Cas 3 24 0 Non-recovery 4 4 11 4 92.3 Yes Yes Yes
7 M 65 Abd 45 Mero 1 24 15 Non-recovery 3 3 18 18 97.5 Yes Yes Yes
8 M 54 Abd 37 Mero 4 24 1 Recovery 6 19 20 20 92.3 Yes Yes Yes
9 M 56 Abd 29 Pip/T-Clinda 3 36 3 Non-recovery 5 16 15 15 78.9 Yes Yes Yes
10 F 51 Abd 32 Levo-Cefta-Cas 1 48 0 Non-recovery 1 10 10 10 85.3 Yes Yes Yes
11 F 49 Abd 29 Mero-Line-Cas 3 48 18 Recovery 3 27 138 33 78.9 No No Yes
12 M 63 Abd 48 Cefta-Line-Cas 1 96 6 Non-recovery 3 14 14 14 98.4 Yes Yes Yes
13 M 72 Abd 34 Pip/T 2 72 4 Non-recovery 3 4 14 5 88.6 Yes Yes Yes
14 M 74 Pneu 33 Mero 5 24 0 Recovery 14 28 40 40 87 No Yes Yes
15 M 65 Pneu 33 Pip/T 3 24 0 Non-recovery 3 4 6 6 87 Yes Yes Yes
16 M 64 Pneu 56 Pip/T 3 24 31 Recovery 11 37 40 40 99.5 No No No
17 M 17 Pneu 29 Cefta-Clon 2 24 0 Unknown 2 2 2 2 78.9 No No No
18 F 72 Pneu 40 Pip/T-Ery 1 24 0 Non-recovery 1 1 1 1 94.9 Yes Yes Yes
19 M 58 Pneu 27 Pip/T-Ery 2 48 13 Chronic 9 16 43 21 73.7 Yes Yes Yes
20 F 79 Pneu 27 Pip/T-Ery-Cas 3 48 30 Recovery 20 34 46 40 73.7 No No No
21 M 62 Pneu 33 Mero-Line 3 48 2 Non-recovery 14 18 20 20 87 Yes Yes Yes
22 M 62 Pneu 54 Pip/T-Clinda 3 48 - Recovery 19 33 35 35 99.3 No Yes Yes
23 F 53 Pneu 33 Pip/t-Ery 2 36 1 Non-recovery 3 3 4 4 87 Yes Yes Yes
24 M 64 Pneu 36 Mero 3 120 47 Recovery 16 45 88 72 91.2 No No Yes
25 M 43 Pneu 52 Pip/T-Ery-Cas 2 120 0 Chronic 3 12 12 12 99.1 Yes Yes Yes
26 M 46 Pneu 44 Pip/T 3 50 0 Non-recovery 7 7 7 7 97.1 Yes Yes Yes
  1. M male, F female, Cat-free catecholamine-free, CRRT continuous renal replacement therapy, Abd abdominal focus, Pneu pneumonia, Cefta Ceftazidim, Mero Meropenem, Pip/T Piperacillin/Taz, Clinda Clindamycin, Ery Erythromycin, Fosfo Fosfomycin, Cas Caspofungin, Line Linezolid, Levo Levofloxacin, Tyga Tigecyclid